Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probucol protection of endothelial progenitor cells in coronary artery disease with hyperlipidemia
ChiCTR-IPR-15007493Phase 4Completed
- Sponsor
- Shandong University
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of probucol in hyperlipidemia and coronary arteriosclerosis (3 arms), sponsored by Shandong University. Primary endpoints: EPCs population in peripheral blood, oxidized low-density lipoprotein and 4 more. Started Aug 2013; status: completed.
02
Drugs
probucol
03
Conditions
hyperlipidemiacoronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR-IPR-15007493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007493.